Denali Therapeutics Inc banner

Wall St Price Targets

DNLI Price Forecast
Based on 18 analysts

+86% Upside
from $19.245 today

Denali Therapeutics Inc (DNLI)’s 12-month stock price forecast through November 2027 has a consensus target of $35.7, implying 86% upside. The forecast is based on price targets from 18 Wall Street analysts.

DNLI Analyst Rating
Based on 20 analysts

avg. 4.8 of 5
Strong buy
17 85%
Buy
2 10%
Hold
1 5%
Sell
0 0%
Strong sell
0 0%

Analysts rate DNLI Strong buy, with 19 of 20 recommending Buy or Strong buy.

Denali Therapeutics Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is DNLI's stock price target?
Price Target
35.7 USD

According to Wall Street analysts, the average 1-year price target for DNLI is 35.7 USD with a low forecast of 23.23 USD and a high forecast of 44.1 USD.

Back to Top